Hamilton Lane Incorporated

Equities

HLNE

US4074971064

Investment Management & Fund Operators

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
112.8 USD +1.70% Intraday chart for Hamilton Lane Incorporated +4.45% -0.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
FundGuard, Inc. announced that it has received $100 million in funding from Hamilton Lane Incorporated, Euclidean Capital LLC, Key 1 Capital Ltd., Team8 Capital, Blumberg Capital, L.L.C. and other investors CI
Rewards startup Fetch taps private credit boom, raising $50 million from Morgan Stanley RE
PAX Health, LLC and funds managed by Hamilton Lane Incorporated acquired Reservoir Health. CI
PAX Health, LLC and Hamilton Lane Incorporated acquired Behavioral Medicine Associates. CI
Sector Update: Financial Stocks Slip Pre-Bell Tuesday MT
Sector Update: Financial MT
Hamilton Lane Prices $210 Million Stock Offering MT
Hamilton Lane, Investor Selling Over 1.9 Million Shares in Public Offering MT
Wells Fargo Adjusts Price Target on Hamilton Lane to $111 From $106, Maintains Equalweight Rating MT
Hamilton Lane Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Hamilton Lane Incorporated, Q3 2024 Earnings Call, Feb 06, 2024
Hamilton Lane's Fiscal Q3 Non-GAAP Earnings Rise, Revenue Falls MT
Hamilton Lane Incorporated Declares Quarterly Dividend, Payable on April 4, 2024 CI
Hamilton Lane Incorporated Appoints Dominik Von Scheven and Principal Taylor McManus as Managing Director to Its Global Real Assets Investments Team CI
Wells Fargo Raises Price Target on Hamilton Lane to $106 From $99, Maintains Equal-Weight Rating MT
UBS Raises Hamilton Lane Price Target to $117 From $93, Maintains Neutral Rating MT
Oppenheimer Downgrades Hamilton Lane to Perform From Outperform, Removes $98 Price Target MT
Morgan Stanley Raises Price Target on Hamilton Lane to $102 From $95, Maintains Equal-Weight Rating MT
Wells Fargo Adjusts Price Target on Hamilton Lane to $89 From $88, Maintains Equalweight Rating MT
Oppenheimer Adjusts Hamilton Lane Price Target to $98 From $97, Maintains Outperform Rating MT
Hamilton Lane Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : Hamilton Lane Incorporated, Q2 2024 Earnings Call, Nov 07, 2023
Hamilton Lane's Fiscal Q2 Adjusted Earnings, Revenue Fall MT
Hamilton Lane Incorporated Targets Dividend for the Full-Year of 2024 CI
Hamilton Lane Incorporated Declares Quarterly Dividend on Class A Common Stock, Payable on January 5, 2024 CI
Chart Hamilton Lane Incorporated
More charts
Hamilton Lane Incorporated is a private market investment management company. The Company works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it enables them to access a diversified set of such investment opportunities worldwide. The Company offers a variety of investment solutions to address its clients needs across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats covering some or all phases of the private market's investment program.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
112.8 USD
Average target price
116 USD
Spread / Average Target
+2.87%
Consensus
  1. Stock
  2. Equities
  3. Stock Hamilton Lane Incorporated - Nasdaq
  4. News Hamilton Lane Incorporated
  5. Sector Update: Financial Stocks Still Resisting Broader Market Declines